Aytu Bioscience (AYTU) a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products has just announced that they confirm delivery and manufacturing of Healight developed by Sterling Devices and Cedars Sinai.
Aytu Bioscience (AYTU) Healight Platform
The Healight platform is a device that is used in conjunction with ventilators and is inserted into the ventilator’s tube. The device uses UV-A light which is broadcasts within the lungs of the COVID-19 patient.
What this means for Aytu Bioscience (AYTU) Investors
The company is getting closer to clinical trials for this new way of using UV-A light, we already know that UV-A light has a tremendous amount of applications, but UV-A within the body is a new feat. Since Aytu signed a master services agreement with Sterling in April for Healight, the Company, Sterling, and its collaborators have sourced Healight device components and finalized design of the investigational devices for use in upcoming clinical studies.
The Healight technology platform employs proprietary methods of administering intermittent ultraviolet (UV) A light via a novel respiratory tract device. Pre-clinical findings indicate the technology’s significant impact on reducing a wide range of viral and bacterial loads, including the coronavirus HCoV-229E. Recently published pre-clinical data have been the basis of discussions with the FDA for a path to enable human use for the potential treatment of SARS-CoV-2 in intubated patients in the intensive care unit (ICU). Beyond the initial pursuit of a potential SARS-CoV-2 ICU indication, additional experimental studies of mixed infection suggest broader potential clinical applications for the technology across a range of viral and bacterial pathogens. This may include nosocomial bacteria implicated in ventilator-associated pneumonia (VAP).
Is Aytu Bioscience (AYTU) a reliable investment?
Shares of Aytu Bioscience (AYTU) appear to be a very good investment option, the Money Midnight Indicator is expecting its price to increase considerably in the next several months. The majority of the metrics point to this investment being highly attractive.
Looking to beat the market?
Sign up and get Money Signals straight to your phone with over 50% in profits! Join now!
